Clinical Trials Browser

Phase 2 × OTHER × Mitotane × Clear all

NCT05634577 2025-06-19

A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma

Phase 2 Terminated

3 enrolled 7 charts

Adrenocortical Carcinoma

NCT06831175 2025-06-03

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Phase 2 Recruiting

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT05913427 2024-08-01

PESETA

Phase 2 Recruiting

Adrenocortical Carcinoma